tiprankstipranks
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market

TherapeuticsMD (TXMD) Income Statement

Compare
2,238 Followers

TherapeuticsMD Income Statement

Last quarter (Q3 2024), TherapeuticsMD's total revenue was $547.00K, a decrease of -1132.08% from the same quarter last year. In Q3, TherapeuticsMD's net income was $-609.00K. See TherapeuticsMD’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 1.30M$ 69.96M$ 86.95M$ 64.87M
Gross Profit
$ 0.00$ 1.30M$ 68.57M$ 68.11M$ 48.90M
Operating Expenses
$ 6.52M$ 9.82M$ 57.90M$ 207.88M$ 204.44M
Depreciation and Amortization
$ 509.00K$ 122.00K$ 1.19M$ 736.00K$ 5.47M
EBITDA
$ -1.83M$ -8.40M$ 11.86M$ -78.57M$ -149.47M
Operating Income
$ -4.76M$ -8.52M$ 20.14M$ -139.77M$ -155.54M
Other Income/Expenses
$ 2.42M$ 781.00K$ -117.00K$ 272.00K$ -27.98M
Pretax Income
$ -2.34M$ -7.74M$ 1.07M$ -172.41M$ -183.52M
Net Income
$ -2.18M$ -10.28M$ 112.00M$ -205.60M$ -212.70M
Per Share Metrics
Basic EPS
$ -0.19$ -0.55$ -10.35$ -25.83$ -38.58
Diluted EPS
$ -0.19$ -0.74$ -10.35$ -25.83$ -38.58
Weighted Average Shares Outstanding
11.53M 13.89M 9.03M 7.96M 5.51M
Weighted Average Shares Outstanding (Diluted)
11.53M 10.44M 9.03M 7.96M 5.51M
Currency in USD

TherapeuticsMD Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis